ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,225.33
-0.27%
Dow Jones
39,136.43
0.06%
Gold vs US Dollar
2,301.61
-0.82%
Brent Oil
84.355
0.20%
Bitcoin
61,452.66
-0.58%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. H Lundbeck AS (PK) (HLUYY)

  7. H Lundbeck AS (PK) (HLUYY) News

H Lundbeck AS (PK) (HLUYY)

H Lundbeck AS (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:HLUYY
DateTimeSourceHeadlineSymbolCompany
12/11/202012:45InvestorWireSavvy Companies Making Moves in Drug-Development SpaceUSOTC:HLUYYH Lundbeck AS (PK)
12/09/201708:02Dow Jones NewsTeva Fills CEO Spot After Long Search -- WSJUSOTC:HLUYYH Lundbeck AS (PK)
11/09/201723:08Dow Jones NewsADRs End Higher; Teva Trades ActivelyUSOTC:HLUYYH Lundbeck AS (PK)
11/09/201719:25Dow Jones NewsTeva Finally Appoints New Chief Executive After Months of Speculation -- 4th UpdateUSOTC:HLUYYH Lundbeck AS (PK)
11/09/201713:42Dow Jones NewsTeva Finally Appoints New Chief Executive After Months of Speculation -- 3rd UpdateUSOTC:HLUYYH Lundbeck AS (PK)
11/09/201711:46Dow Jones NewsTeva Names Kare Schultz as New Chief Executive -- 2nd UpdateUSOTC:HLUYYH Lundbeck AS (PK)
11/09/201709:03Dow Jones NewsTeva Names Kare Schultz as New Chief Executive -- UpdateUSOTC:HLUYYH Lundbeck AS (PK)
19/08/201516:30Dow Jones NewsDrugmaker H. Lundbeck to Cut Staff, CostsUSOTC:HLUYYH Lundbeck AS (PK)
06/05/201508:39Dow Jones NewsLundbeck Names New CEO After 1Q Net LossUSOTC:HLUYYH Lundbeck AS (PK)
26/02/201509:47Dow Jones NewsDONG Energy Nominates Skole and Armstrong to BoardUSOTC:HLUYYH Lundbeck AS (PK)
08/05/201412:58GlobeNewswire Inc.Chelsea Therapeutics to Host Conference Call to Discuss Acquisition by LundbeckUSOTC:HLUYYH Lundbeck AS (PK)
08/05/201412:54GlobeNewswire Inc.Lundbeck to Acquire Chelsea TherapeuticsUSOTC:HLUYYH Lundbeck AS (PK)
06/02/201417:34Dow Jones NewsEUROPE MARKETS: European Stocks Rally After ECB, BOE Rate CallsUSOTC:HLUYYH Lundbeck AS (PK)
06/02/201417:19Dow Jones NewsEUROPE MARKETS: European Stocks Stay Higher After ECB, BOE Rate CallsUSOTC:HLUYYH Lundbeck AS (PK)
06/02/201417:11Dow Jones NewsEUROPE MARKETS: European Stocks Rally Ahead Of ECB Rate CallUSOTC:HLUYYH Lundbeck AS (PK)
06/02/201416:03Dow Jones NewsEUROPE MARKETS: European Stocks Climb Ahead Of ECB, BOE Rate CallsUSOTC:HLUYYH Lundbeck AS (PK)
06/02/201409:55Dow Jones NewsEUROPE MARKETS: European Stocks Climb Ahead Of ECB, BOE Rate CallsUSOTC:HLUYYH Lundbeck AS (PK)
22/03/201300:00OTC MarketsEx-DividendUSOTC:HLUYYH Lundbeck AS (PK)
20/03/201314:57Dow Jones NewsTeva Pharmaceutical Parkinson's Treatment Meets Study GoalsUSOTC:HLUYYH Lundbeck AS (PK)
09/03/201301:00OTC MarketsScheduled Ex-DividendUSOTC:HLUYYH Lundbeck AS (PK)
13/09/201218:15Dow Jones NewsLundbeck to Halt Sale of Leukemia Drug, Citing Supply ProblemsUSOTC:HLUYYH Lundbeck AS (PK)
 Showing the most relevant articles for your search:USOTC:HLUYY

Your Recent History

TG
600389
AXA
BIT
UC103J
Unicredit Bank
COIN
MAPPETH
MAP Protocol
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved